Home Business Scenarios

Business Scenarios
Business Scenarios PDF Print E-mail

At Katsock & Company, building value and ensuring compliancy are two cornerstones of our business.  There is quite possibly no better gauge to our success in these areas than the successful outcomes we’ve helped ensure for our clients.  The following client scenarios explain the impact and effect we’ve had on our clients’ business.  Company names have been changed omitted for anonymity and confidentiality purposes.

Katsock & Company manages the tax function for various public and private companies.  Some recent accomplishments include working with a:

  • $250M publicly-held multinational biotechnology company that develops innovative products that address unmet medical needs.  Provided income tax provisions, tax planning and compliance, merger and acquisition planning, and state tax planning minimization.
    • Accomplishments: Built out the tax function and developed procedures to comply with FAS 109 and SOX 404; led tax contact for $500MM+ acquisition of another public company; developed and streamlined tax compliance procedures and implemented tax provision technology to increase accuracy and reduce potential error exposure.
  • $265M publicly-held holding company that builds value in growth-stage technology and life sciences businesses.  Provided income tax provision outsourcing, tax planning and compliance, merger and acquisition planning and due diligence of investment alternatives.
    • Accomplishments: Built out the tax function, developed procedures to comply with FAS 109 and SOX 404; streamlined tax compliance procedures and led tax contact for firms entries and exits into/out of investments.
  • $200M pharmaceutical chemical company.  Provided tax planning and compliance, state tax planning and minimization.
    • Accomplishments: Negotiated with state tax jurisdictions to increase incentive credits $500k; identified tax opportunities resulting in savings of ~$2MM; enhanced and streamlined reporting and compliance function.
  • development stage biopharmaceutical company focused on the discovery and development of novel product.  Provided income tax provision outsourcing, tax planning and compliance, build out of tax function, state tax planning minimization and merger and acquisition planning.
    • Accomplishments: Identified opportunities to increase tax attributes; streamlined compliance function to increase available federal/state credits and streamlined FAS 109 reporting.